Global Vaccine Vials Market Report and Forecast 2024-2032

Global Vaccine Vials Market Outlook

The global vaccine vials market size was valued at USD 22.56 billion in 2023, driven by the rising research and development of vaccines across the globe. The market is expected to grow at a CAGR of 6.70% during the forecast period of 2024-2032, with the values likely to rise from USD 24.07 billion in 2024 to USD 40.44 billion by 2032.

Global Vaccine Vials Market Overview

Vaccines help to protect the body from various illnesses, particularly bacterial and viral infectious/non-infectious diseases. They are stored in cylindrical units called vaccine vials. The rise in infectious diseases has fuelled the production of vaccines. In 2023, around 64 infectious diseases were reported to affect individuals spanning across 235 countries. The surge in vaccine production to combat infectious diseases and other medical conditions has led to an increased vaccine vials market demand.

The increased investment in the research and development of vaccines is also bolstering the market growth for vaccine vials. In April 2023 , SK Bioscience, a vaccine development company based in South Korea, announced its plan to invest USD 1.8 billion in its vaccine and contract development and manufacturing organization (CDMO) businesses. They intend for strategic mergers and acquisitions initiatives in the vaccine domain, among others. With half of the investment reserved for vaccine development, the company plans to develop 5 more vaccine pipelines.

The vaccine vials market growth is also driven by the growing awareness among patients about immunization and its benefits. The rising healthcare expenditure to improve patient outcomes is another factor that will aid in the expansion of the market size.

Global Vaccine Vials Market Segmentation

Market Breakup by Type

• Single Dose

• Multiple Dose

The global vaccine vials market is segmented by type into single dose and multiple dose vials. Single dose vials are designed to contain a single dose of vaccine. It is commonly used for vaccines that require individual dosing or for vaccines with stability issues once opened. On the other hand, multiple dose vials are designed to contain multiple doses of vaccine.

Market Breakup by Material

• Glass

• Polymer

Based on the material, the market is divided into glass and polymer. Glass vials offer high transparency and compatibility with a wide range of pharmaceutical products. Polymer vials are cheaper and are often preferred for vaccines with less stringent storage requirements.

Market Breakup by Capacity

• 10 ml

• 20 ml

• 5 ml

• 3ml

• 2ml

The vaccine vials market share is segmented by capacity into various sizes, including 10 ml, 20 ml, 5 ml, 3 ml, and 2 ml vials. For higher doses or multiple administrations, larger capacities like 10 ml and 20 ml are preferred. For lower dosage requirements or individual doses, smaller capacities such as 5 ml, 3 ml, and 2 ml are considered ideal.

Market Breakup by Application

• Preventive Vaccine

• Therapeutics Vaccine

The market for vaccine vials is categorized by application into preventive vaccines and therapeutic vaccines. This segmentation reflects the diverse applications of vaccine vials, catering to different healthcare settings and needs.

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

The market report offers deep insights into major regional markets such as North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is expected to led the market share, owing to the presence of multiple pioneering pharmaceutical and biotechnology companies, research facilities, and a robust healthcare infrastructure. With prominent academic institutions, Europe is also anticipated to hold a significant market size in the forecast period.

Global Vaccine Vials Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Cardinal Health Inc.

• Nipro Corporation

• Thermo Fisher Scientific Inc.

• Zebra Technologies Corporation,

• Schott AG,

• Gerresheimer AG

• Lisaline Lifescience Technologies Pvt Ltd.

• DWK Life Sciences GmbH

• Catalent, Inc.,

• EVIGENCE SENSORS Inc.,

• Richland Glass Company Inc.

• Vetter Pharma

• Pacific Vial Manufacturing Inc.,

• Berlin Material Type LLC

• Stevanato Group

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Key Queries Solved in the Global Vaccine Vials Market Report

• How will the market landscape evolve in the coming years? 
• What are the key market trends influencing the market? 
• What are the major drivers, opportunities, and restraints in the market? 
• Which country is poised to lead the market share in the forecast period? 
• Which country is expected to experience expedited growth during the forecast period? 
• What types of vaccine vials are available in the market? 
• Which vaccine vial material is expected to dominate the respective market segment? 
• Which key market players are projected to influence the market?
• What are the key research initiatives expected to boost the vaccine vials market share during the forecast period? 
• What technological advancements and innovations are influencing vaccine vial design, materials, and manufacturing processes?
• Which segment has the most major impact on the market size? 
• How did the COVID-19 pandemic affected the vaccine vials market?
• How are partnerships, collaborations, and mergers & acquisitions shaping the market dynamics?